CPT code 86200 denotes a laboratory serology test that detects cyclic citrullinated peptide (CCP) antibodies, an important biomarker used to differentiate rheumatoid arthritis (RA) from other arthritides. Nationally, CCP testing influences diagnostic pathways, early therapeutic decisions, and disease classification for patients with suspected inflammatory arthritis.

Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication summarizes coverage and billing context across major commercial and federal payers and explains how CPT code 86200 is used in clinical workflows and claims processing.

Readers will find concise clinical context about CCP antibody testing, the typical laboratory service setting, and what this code represents on a claim. The report provides benchmarks and payer-focused observations where available, highlights common billing and documentation considerations, and outlines policy developments that affect lab reimbursement and utilization. Data not available in the input are noted where applicable.